Krystexxa 8MG
Ended Awarded
- Contract number
- 36C24524N0340
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $55,903
Award facts
- Contract value 100% obligated
- $55,903.32 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- La Vergne, TN 37086, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a delivery order to Horizon Therapeutics USA Inc. for KRYSTEXXA 8MG, a specialty pharmaceutical product. The order, valued at $55,903.32, was placed against Horizon Therapeutics' Multiple Award Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and did not have a set-aside designation. Horizon Therapeutics is a global biotechnology company that provides orphan drugs and specialty pharmaceuticals to support healthcare services for veterans. The company holds an $18 million Blanket Purchase Agreement with the VA for Ravicti, Buphenyl, Krystexxa, Procysbi and Actimmune, in addition to a $25 million Pharmaceuticals and Drugs Schedule contract, both of which the VHA has utilized to procure the specialized medications required to fulfill its mission.
Quick answers
Who was awarded contract 36C24524N0340?
36C24524N0340 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 17, 2024.
How much is contract 36C24524N0340 worth?
The government has obligated $55,903 on 36C24524N0340.
Is contract 36C24524N0340 an order under another contract?
Yes. 36C24524N0340 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0340 competed?
The extent of competition for 36C24524N0340 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award